All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

FRET-based assay for intracellular evaluation of alpha-synuclein aggregation inhibitors

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216208%3A11310%2F21%3A10441790" target="_blank" >RIV/00216208:11310/21:10441790 - isvavai.cz</a>

  • Result on the web

    <a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kIrSw.71eZ" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=kIrSw.71eZ</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1111/jnc.15528" target="_blank" >10.1111/jnc.15528</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    FRET-based assay for intracellular evaluation of alpha-synuclein aggregation inhibitors

  • Original language description

    Aggregation of small neuronal protein alpha-synuclein (alpha Syn) in amyloid fibrils is considered to be one of the main causes of Parkinson&apos;s disease. Inhibition of this aggregation is a promising approach for disease treatment. Dozens of compounds able to inhibit alpha Syn fibrillization in solution were developed during the last decade. However, the applicability of most of them in the cellular environment was not established because of the absence of a suitable cell-based assay. In this work, we developed an assay for testing alpha Syn aggregation inhibitors in cells that is based on fluorescence resonance energy transfer (FRET) between labeled alpha Syn molecules in fibrils. The assay directly reports the amount of fibrillized alpha Syn and is more reliable than the assays based on cell viability. Moreover, we showed that cell viability decline does not always correlate with the amount of misfolded alpha Syn. The developed FRET-based assay does not interfere with the aggregation process and is suitable for high-throughput testing of alpha Syn aggregation inhibitors. Its application can sort out non-specific inhibitors and thus significantly facilitate the development of drugs for Parkinson&apos;s disease.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    30103 - Neurosciences (including psychophysiology)

Result continuities

  • Project

  • Continuities

    S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2021

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Journal of Neurochemistry

  • ISSN

    0022-3042

  • e-ISSN

  • Volume of the periodical

    159

  • Issue of the periodical within the volume

    5

  • Country of publishing house

    GB - UNITED KINGDOM

  • Number of pages

    12

  • Pages from-to

    901-912

  • UT code for WoS article

    000715432700001

  • EID of the result in the Scopus database

    2-s2.0-85118592475